A detailed history of Sectoral Asset Management Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Sectoral Asset Management Inc holds 27,200 shares of LEGN stock, worth $1.11 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares
27,200
Previous 2,000 1260.0%
Holding current value
$1.11 Million
Previous $88,000 1405.68%
% of portfolio
1.11%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.55 - $59.88 $1.1 Million - $1.51 Million
25,200 Added 1260.0%
27,200 $1.33 Million
Q2 2024

Aug 13, 2024

SELL
$39.5 - $57.22 $39,500 - $57,220
-1,000 Reduced 33.33%
2,000 $88,000
Q4 2023

Feb 14, 2024

SELL
$57.25 - $69.74 $210,107 - $255,945
-3,670 Reduced 55.02%
3,000 $180,000
Q3 2023

Nov 14, 2023

SELL
$63.16 - $76.5 $84,002 - $101,745
-1,330 Reduced 16.63%
6,670 $448,000
Q2 2023

Aug 11, 2023

SELL
$46.28 - $75.01 $92,560 - $150,020
-2,000 Reduced 20.0%
8,000 $552,000
Q1 2023

May 12, 2023

BUY
$43.42 - $57.37 $43,420 - $57,370
1,000 Added 11.11%
10,000 $482,000
Q3 2022

Nov 10, 2022

SELL
$38.15 - $57.1 $38,150 - $57,100
-1,000 Reduced 10.0%
9,000 $367,000
Q2 2022

Aug 15, 2022

SELL
$33.54 - $55.0 $67,080 - $110,000
-2,000 Reduced 16.67%
10,000 $550,000
Q1 2022

May 10, 2022

BUY
$31.02 - $48.18 $155,100 - $240,900
5,000 Added 71.43%
12,000 $436,000
Q4 2021

Feb 11, 2022

SELL
$41.14 - $56.98 $16,456 - $22,792
-400 Reduced 5.41%
7,000 $326,000
Q2 2021

Aug 16, 2021

SELL
$25.8 - $41.09 $74,820 - $119,161
-2,900 Reduced 28.16%
7,400 $304,000
Q1 2021

May 14, 2021

BUY
$23.55 - $32.4 $242,565 - $333,720
10,300 New
10,300 $299,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.85B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.